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Fluorescent X-ray computed tomography (FXCT) enables visualization of
myocardial fatty acid metabolism by using non-radio-iodinated I-5-(p-iodo-
phenyl)-3-(R,S)-methylpentadecanoice acid (BMIPP). In this experiment, age-
dependent myocardial metabolic impairment was successfully imaged and
analyzed quantitatively in J2N-k cardiomyopathic hamster using FXCT.
Keywords: fluorescent X-ray computed tomography; age-dependent metabolic impairment;
cardiomyopathy; myocardial fatty acid; BMIPP.
1. Introduction
Using various radionuclide chemical agents, micro-imaging
techniques such as micro-positron emission tomography
(PET) and micro-single-photon emission computed tomo-
graphy (SPECT) play an important role in basic biomedical
research to assess the functional impairment of small animals
using various heart disease models.
Fluorescent X-ray methods are used as highly sensitive
imaging techniques to detect very low contents of non-radio-
active media and/or heavy-atomic-number elements. Thus, we
originally designed a ﬂuorescent X-ray computed-tomography
(FXCT) imaging system that did not require the preparation
of specimens like in planar mode (Takeda, Akiba et al., 1996),
and the sensitivity of the FXCTwas about 80-fold higher than
that of absorption X-ray computed tomography (CT) (Yu et
al., 2001). The cross-sectional distribution of iodine in human
thyroid was imaged ﬁrst (Rust & Weigelt, 1998; Takeda et
al., 2000, 2001), and our interests are now towards the use
of FXCT in determining tracer elements including iodine.
Since radio-iodinated I-5-(p-iodophenyl)-3-(R,S)-methyl-
pentadecanoic acid (123I-BMIPP) is a potential tracer for
detecting the myocardial fatty acid metabolism in clinical
SPECT studies (Fujibayashi et al., 1990; Inoue et al., 2007;
Ogata, 1989; Thet-Thet-Lwin et al., 2003), we chose to use this
agent for FXCT imaging. We successfully imaged the state of
the impaired myocardial fatty acid metabolism in a 22-week-
old J2N-k cardiomyopathic model hamster using our FXCT
system with non-radio-iodinated BMIPP (127I-BMIPP) (Thet-
Thet-Lwin et al., 2007).
The J2N-k cardiomyopathic hamster, obtained by cross-
breeding a Bio14.6 cardiomyopathic Syrian hamster and a
Golden hamster, is a standard model of cardiomyopathy.
J2N-k hamsters begin to show slight ﬁbrosis at eight weeks
old, exhibit moderate cardiac dysfunction, degeneration of
cardiomyocyte and interstitial ﬁbrosis at about 20 weeks, and
ﬁnally die owing to congestive heart failure when approxi-
mately one year old (Saito et al., 1998; Nagano & Saito, 1998).
Recently, these biological data, exhibiting a variety of meta-
bolic abnormalities, have provided us with important infor-
mation for understanding human cardiac disease and for
ﬁnding keys for earlier diagnosis and therapy for human
cardiomyopathy. By extending the achievement of our
previous result, here the age-dependent myocardial fatty acid
metabolic impairment was imaged and analyzed quantitatively
in J2N-k cardiomyopathic hamsters by FXCT using
127I-BMIPP.
2. Materials and methods
2.1. Objects and preparation
Eight-week, 12-week, 15-week, 20-week and 25-week J2N-k
cardiomyopathic hamsters and age-matched J2N-n normal
hamsters were examined. 127I-BMIPP (0.08 mg g1 weight)
was injected through the femoral vein of each hamster under
anesthesia. Each heart labelled with BMIPP was extracted
after 5 min of injection and ﬁxed by formalin. Experiments
were undertaken in accordance with the Medical Committee
for the Use of Animals in Research of the University of
Tsukuba, and conformed to the guidelines of the American
Physiological Society.
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2.2. FXCT
FXCT was carried out using a silicon (220) double-crystal
monochromator to select the X-ray energy, an X-ray slit
system, a scanning table for the subject, a highly puriﬁed Ge
detector with a parallel collimator, two pin-diode detectors
and a computer system (Fig. 1) (Thet-Thet-Lwin et al., 2007).
The monochromatic X-ray energy was set to 37 keV to
separate the peak energy of the ﬂuorescent iodine K line
from Compton scatter (Takeda, Maeda et al., 1996). The
photon ﬂux in front of the object was approximately
108 photons mm2 s1, and the X-ray absorption dose was
2.7 Gy. The incident monochromatic X-ray beam was colli-
mated into a pencil beam with square cross section (0.25 mm
 0.5 mm) using the X-ray slit system. Fluorescent X-rays
were detected by the HPGe detector in photon-counting
mode. Furthermore, to reduce the amount of Compton
radiation captured by the same detector, the HPGe detector
was positioned perpendicular to the incident monochromatic
X-ray beam. Experiments were carried out at the synchrotron
X-ray source at the Photon Factory, High Energy Accelerator
Research Organization, Tsukuba, Japan.
2.3. FXCT data acquisition parameter and reconstruction
The formalin-ﬁxed heart labelled with BMIPP was imaged
by FXCT when placed in an acrylic object cell. Here, two
short-axis slices at mid-ventricular level of a cardiomyopathic
hamster heart (1 mm interval) and one short-axis slice from a
normal hamster were imaged.
The projection data were acquired at each sampling point
from 0.25 mm translational steps over the sample diameter
and 3 rotational steps over 180. The data acquisition time for
each sampling point was 7 s. By observing the spectrum of the
iodine ﬂuorescent K line at each CT scanning step, the
distribution of iodine in the object was imaged. FXCT images
were reconstructed using the algebraic reconstruction tech-
nique including the attenuation process of the incident beam
and the emitted ﬂuorescent X-ray within the object (Yuasa et
al., 1997).
2.4. Quantitative image analysis
For quantitative analysis of FXCT images, the left-ventricle
image was divided into four regions, i.e. the anterior wall,
lateral wall, inferior wall and septum, interactively. The
ﬂuorescent X-ray intensity of iodine was measured in each
region of the normal and cardiomyopathic myocardium.
The myocardial BMIPP uptake was estimated by referring to
the linear regression curve between the ﬂuorescent X-ray
intensity and iodine concentration using a basic phantom
study, as described previously (Thet-Thet-Lwin et al., 2007).
For each region the relative uptake of BMIPP was deﬁned
as the ratio of regional intensity to maximal intensity in the
four regions.
2.5. Quantitative image analysis
The results are expressed as the mean  standard deviation
(SD) and are analyzed by unpaired t-test. A value of prob-
ability p < 0.01 was considered statistically signiﬁcant.
3. Results
Typical FXCT images are shown in Fig. 2. In normal hamsters
of all ages and cardiomyopathic hamsters of age eight weeks
the BMIPP was distributed almost homogeneously. However,
in the cardiomyopathic hamsters at age 12 weeks the BMIPP
uptake decreased slightly and was distributed hetero-
geneously. In the cardiomyopathic hamsters aged more than
12 weeks the distribution of BMIPP became progressively
more heterogeneous. At 25 weeks the BMIPP uptake
decreased signiﬁcantly in the septum and inferior wall. The
distribution of the BMIPP uptake was not signiﬁcantly
different between two slices in the same cardiomyopathic
hamster.
The relationship between the myocardial area and BMIPP
uptake for normal and cardiomyopathic hamsters is shown in
Fig. 2(b). The myocardial BMIPP uptake in the cardiomyo-
pathic hamsters shifted to a lower value compared with that
of the normal hamsters. To assess the myocardial area with
reduced fatty acid metabolism for each age of the cardio-
myopathic hamsters, a lower limit of the normal BMIPP
uptake value was set as the mean BMIPP uptake value minus
2SD for the normal hamsters.
The percentage of the myocardial area with reduced fatty
acid metabolism was 7.5%, 17.1%, 24.3% and 47.4% of the
whole of the left myocardium for eight-, 12-, 15- and 25-week
cardiomyopathic hamsters, respectively. The mean BMIPP
uptake in age-matched normal and cardiomyopathic hamsters
was 178.2  19.2 mg ml1 versus 171.4  20.7 mg ml1, 178.6 
19.1 mg ml1 versus 163.7 23.5 mg ml1, 176.3 20.8 mg ml1
versus 155.9  26.3 mg ml1, and 180.1  20.1 mg ml1 versus
143.3  29.1 mg ml1 for ages of eight weeks, 12 weeks, 15
weeks and 25 weeks, respectively (Fig. 2c). The mean BMIPP
uptake values of the cardiomyopathic myocardium were
signiﬁcantly decreased at 15 and 25 weeks (p < 0.05).
The relative regional BMIPP uptake for all ages of normal
and cardiomyopathic hamsters is given in Table 1. In the
research papers
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Figure 1
Schematic diagram of the ﬂuorescent X-ray CT system.
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normal hamsters and cardiomyopathic hamsters aged less than
12 weeks the relative uptake of BMIPP was not signiﬁcantly
different in any region. However, in the cardiomyopathic
hamsters the relative BMIPP uptake decreased signiﬁcantly in
the septum and inferior wall for those hamsters more than 15
weeks old (Table 1).
The morphological structures such as papil-
lary muscle, wall thickness and left-ventricular
diameter were revealed clearly by FXCT,
as shown in Fig. 2(a). In cardiomyopathy
an increased left-ventricular diameter and
decreased wall thickness were observed from
15 weeks, and the signiﬁcant left-ventricular
dilatation and wall thinning occurred at 25
weeks.
4. Discussion
The FXCT revealed almost homogeneous
myocardial BMIPP accumulation in normal
hamsters aged from eight to 25 weeks and in
cardiomyopathic hamsters aged eight weeks.
However, BMIPP accumulated heterogeneously and its
uptake decreased in cardiomyopathic hamsters aged more
than 12 weeks; in particular, the degree of decreased BMIPP
uptake was prominent in the inferior wall and septum. The
regional heterogeneity of BMIPP accumulation was observed
signiﬁcantly in the older cardiomyopathic hamsters. Abnormal
research papers
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Table 1
Relative regional uptake of BMIPP in normal and cardiomyopathic hamsters.
Objects are one normal hamster per age group (n = 1) and two hamsters (n = 2) for
cardiomyopathy. n.s. = not statistically signiﬁcant.
Regions
Group Anterior wall Lateral wall Inferior wall Septum p value
Control
(8–25 weeks: n = 1)
0.95  0.04 0.92  0.05 0.95  0.05 0.98  0.02 n.s.
Cardiomyopathy
(8 weeks: n = 2)
0.93  0.08 0.91  0.08 0.92  0.09 0.94  0.05 n.s.
Cardiomyopathy
(12 weeks: n = 2)
0.96  0.05 0.87  0.09 0.87  0.08 0.94  0.10 n.s.
Cardiomyopathy
(15 weeks: n = 2)
0.97  0.07 0.94  0.08 0.73  0.05† 0.83  0.07† <0.01
Cardiomyopathy
(25 weeks: n = 2)
0.96  0.07 0.93  0.06 0.71  0.06† 0.77  0.08† <0.01
† Statistically signiﬁcant; lower value in inferior wall and septum.
Figure 2
(a) FXCT images of mid-ventricular slices, and (b) the distribution of myocardial BMIPP uptake corresponding to the slices in (a). (c) The average
BMIPP uptake for each case in (a). Ant: anterior wall; Lat: lateral wall; Inf: inferior wall.
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accumulation of BMIPP depicted by FXCT was more severe
than expected from histological changes, and the BMIPP
uptake was also decreased in the inferior wall and septum at
20 weeks for the J2N-k cardiomyopathgic hamster (Thet-Thet-
Lwin et al., 2003, 2007). In addition, the area of reduced
BMIPP uptake increased progressively depending on age. The
area with reduced BMIPP uptake (47.4% at the mid-left
ventricle) at 25 weeks was 6.3 times broader than that at eight
weeks. This phenomenon is considered to be due to myocar-
dial metabolic impairment in the cardiomyopathic hearts
because similar pathological changes in fatty acid metabolism
were also reported in previous studies using radio-iodinated
BMIPP (Mochizuki et al., 1997; Thet-Thet-Lwin et al., 2003,
2004).
In addition, morphological changes such as left-ventricular
dilatation and decreased wall thickness were observed in the
late phase of cardiomyopathy, and these changes had occurred
more severely and more prominently in the older cardio-
myopathic hamsters.
Thus, FXCT could clearly depict the transition of the age-
dependent fatty acid metabolism, and was able to assess the
quantitative analysis for cardiomyopathy. As an alternative
technique to the conventional autoradiogram with radioactive
agents, FXCT has the advantage of not using any radioactive
agent. For researchers and pharmacologists the use of a non-
radioactive agent allows easy preparation and observation of
samples using various pathological staining techniques, and
effective development of new drugs without considering and
protecting against radiation exposure.
On our prototype FXCT system (Takeda et al., 2004;
Takeda, 2005), long data acquisition times are required, i.e.
seven hours per slice to image with 0.25 mm spatial resolution.
Therefore we are now introducing a new mechanical scanning
technique to reduce the scan points outside the object, and a
revised detector system to obtain FXCT data much faster.
With an improved FXCT system, CT data are expected to be
acquired about 28 times faster than with the present prototype
system by shortening the distance between the detector and
the object from 80 mm to 15 mm. This allows the data acqui-
sition time to be shortened to 15 min, and exposure to be
reduced to less than 100 mGy.
Since FXCT can image the object using the CT conﬁgura-
tion, this technique can also be used in in vivo observation. At
present, in vivo imaging techniques, such as micro-SPECT or
micro-PET, of small animals are under development; however,
for both techniques the use of radionuclide agents is indis-
pensable, and their spatial resolutions are limited to 1 mm
and 1–0.5 mm, respectively. The FXCT system provides an
in vitro imaging with 0.25 mm spatial resolution, so this tech-
nique might be used for high-spatial-resolution in vivo
imaging without radionuclide agent. Therefore, FXCT might
be used as a molecular imaging technique to analyze the
various myocardial conditions in small animals considered as
human disease models.
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